Compare ARCT & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARCT | RWAY |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.9M | 274.5M |
| IPO Year | 2019 | 2015 |
| Metric | ARCT | RWAY |
|---|---|---|
| Price | $8.37 | $6.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $23.80 | $8.11 |
| AVG Volume (30 Days) | ★ 653.3K | 291.0K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 20.27% |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | $2.98 |
| Revenue Next Year | $8.84 | $1.40 |
| P/E Ratio | ★ N/A | $83.06 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $5.19 |
| 52 Week High | $17.96 | $9.62 |
| Indicator | ARCT | RWAY |
|---|---|---|
| Relative Strength Index (RSI) | 36.93 | 55.85 |
| Support Level | $6.45 | $6.31 |
| Resistance Level | $8.69 | $6.85 |
| Average True Range (ATR) | 1.06 | 0.19 |
| MACD | -0.12 | 0.03 |
| Stochastic Oscillator | 5.32 | 81.76 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States. The company's investment objective is to maximize its total return to its stockholders through current income on its loan portfolio, and secondarily through capital gain on its warrants and other equity positions.